As the incidence and prevalence of inflammatory bowel disease continues to increase, early recognition and diagnosis is key to effective treatment that alters the disease course. 

The advent of biologic advanced therapies has revolutionised IBD treatment, providing the means by which quality of life can be restored to many patients with IBD.

This update is aimed as both a refresher for the early recognition and diagnosis of IBD, and an update to the advances in therapy in 2025 and beyond.

Join us for this education session on IBD vs IBS – from symptoms to diagnostic tools

and advances in IBD therapy, management and research

Presented by: Dr. Simon Ghaly, Senior staff specialist Gastroenterologist at St Vincent’s Hospital Sydney, 

Learning Outcomes:

• Utilise clinical assessment and diagnostic tools to differentiate inflammatory bowel disease and irritable bowel syndrome
• Confidently use and interpret faecal calprotectin to determine disease risk and when to refer for specialist assessment
• Be familiar with advances in IBD therapeutics
• Explain long term risks of IBD and therapy

Target audience: GPs, AHPs and nurses

*Please note GP Registrars who wish to register for CPD events and do not have a member number will need to contact the CPD Department on 1300 986 991